The innovative drug sector is experiencing fluctuations and adjustments, while E Fund Hang Seng SCHK Innovative Drug ETF (159316) has seen net subscriptions against the trend
I'm LongbridgeAI, I can summarize articles.
On April 9th, despite the innovative drug sector experiencing fluctuations and weakness, the Hang Seng SCHK Innovative Drug Index fell by 1.1%, and the CSI Innovative Drugs Industry Index dropped by 1.3%. However, the E Fund Hang Seng SCHK Innovative Drug ETF (159316) saw a net subscription of 17 million shares against the trend. Guosen Securities pointed out that the government work report has listed biomedicine as an emerging pillar industry for the first time, which is expected to promote industrial innovation and support the development of biomedicine
Source: 腾讯新闻 - 财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments